BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17255202)

  • 1. Hyperglycemia alters the responsiveness of smooth muscle cells to insulin-like growth factor-I.
    Maile LA; Capps BE; Ling Y; Xi G; Clemmons DR
    Endocrinology; 2007 May; 148(5):2435-43. PubMed ID: 17255202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor-I signaling in smooth muscle cells is regulated by ligand binding to the 177CYDMKTTC184 sequence of the beta3-subunit of alphaVbeta3.
    Maile LA; Busby WH; Sitko K; Capps BE; Sergent T; Badley-Clarke J; Clemmons DR
    Mol Endocrinol; 2006 Feb; 20(2):405-13. PubMed ID: 16195248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of igf-I signaling in retinal endothelial cells by hyperglycemia.
    Miller EC; Capps BE; Sanghani RR; Clemmons DR; Maile LA
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3878-87. PubMed ID: 17652764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the human beta3 integrin subunit in mouse smooth muscle cells enhances IGF-I-stimulated signaling and proliferation.
    Xi G; Maile LA; Yoo SE; Clemmons DR
    J Cell Physiol; 2008 Feb; 214(2):306-15. PubMed ID: 17607710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of SHPS-1 in the regulation of insulin-like growth factor I-stimulated Shc and mitogen-activated protein kinase activation in vascular smooth muscle cells.
    Ling Y; Maile LA; Lieskovska J; Badley-Clarke J; Clemmons DR
    Mol Biol Cell; 2005 Jul; 16(7):3353-64. PubMed ID: 15888547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the integrin alphaVbeta3 in mediating increased smooth muscle cell responsiveness to IGF-I in response to hyperglycemic stress.
    Clemmons DR; Maile LA; Ling Y; Yarber J; Busby WH
    Growth Horm IGF Res; 2007 Aug; 17(4):265-70. PubMed ID: 17412627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking ligand occupancy of the alphaVbeta3 integrin inhibits insulin-like growth factor I signaling in vascular smooth muscle cells.
    Zheng B; Clemmons DR
    Proc Natl Acad Sci U S A; 1998 Sep; 95(19):11217-22. PubMed ID: 9736716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor-I stimulates Shc-dependent phosphatidylinositol 3-kinase activation via Grb2-associated p85 in vascular smooth muscle cells.
    Radhakrishnan Y; Maile LA; Ling Y; Graves LM; Clemmons DR
    J Biol Chem; 2008 Jun; 283(24):16320-31. PubMed ID: 18420583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of ligand occupancy in Insulin-like growth factor-I (IGF-I) induced cell growth in osteoblast like MC3T3-E1 cells.
    Kim SK; Kwon JY; Nam TJ
    Biofactors; 2007; 29(4):187-202. PubMed ID: 18057550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic alphaVbeta3 antagonists inhibit insulin-like growth factor-I-stimulated smooth muscle cell migration and replication.
    Clemmons DR; Horvitz G; Engleman W; Nichols T; Moralez A; Nickols GA
    Endocrinology; 1999 Oct; 140(10):4616-21. PubMed ID: 10499518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrin-associated protein binding domain of thrombospondin-1 enhances insulin-like growth factor-I receptor signaling in vascular smooth muscle cells.
    Maile LA; Clemmons DR
    Circ Res; 2003 Nov; 93(10):925-31. PubMed ID: 14563713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Src kinase in insulin-like growth factor-dependent mitogenic signaling in vascular smooth muscle cells.
    Lieskovska J; Ling Y; Badley-Clarke J; Clemmons DR
    J Biol Chem; 2006 Sep; 281(35):25041-53. PubMed ID: 16825188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrin-associated protein association with SRC homology 2 domain containing tyrosine phosphatase substrate 1 regulates igf-I signaling in vivo.
    Maile LA; Capps BE; Miller EC; Aday AW; Clemmons DR
    Diabetes; 2008 Oct; 57(10):2637-43. PubMed ID: 18633106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between insulin-like growth factor-I receptor and alphaVbeta3 integrin linked signaling pathways: cellular responses to changes in multiple signaling inputs.
    Clemmons DR; Maile LA
    Mol Endocrinol; 2005 Jan; 19(1):1-11. PubMed ID: 15528274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor-I-stimulated insulin receptor substrate-1 negatively regulates Src homology 2 domain-containing protein-tyrosine phosphatase substrate-1 function in vascular smooth muscle cells.
    Radhakrishnan Y; Busby WH; Shen X; Maile LA; Clemmons DR
    J Biol Chem; 2010 May; 285(21):15682-95. PubMed ID: 20207740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling.
    Cousin SP; Hügl SR; Myers MG; White MF; Reifel-Miller A; Rhodes CJ
    Biochem J; 1999 Dec; 344 Pt 3(Pt 3):649-58. PubMed ID: 10585851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DOK1 mediates SHP-2 binding to the alphaVbeta3 integrin and thereby regulates insulin-like growth factor I signaling in cultured vascular smooth muscle cells.
    Ling Y; Maile LA; Badley-Clarke J; Clemmons DR
    J Biol Chem; 2005 Feb; 280(5):3151-8. PubMed ID: 15546884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p66shc negatively regulates insulin-like growth factor I signal transduction via inhibition of p52shc binding to Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 leading to impaired growth factor receptor-bound protein-2 membrane recruitment.
    Xi G; Shen X; Clemmons DR
    Mol Endocrinol; 2008 Sep; 22(9):2162-75. PubMed ID: 18606861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual role of SRC homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells.
    Sasaoka T; Kikuchi K; Wada T; Sato A; Hori H; Murakami S; Fukui K; Ishihara H; Aota R; Kimura I; Kobayashi M
    Endocrinology; 2003 Sep; 144(9):4204-14. PubMed ID: 12933696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
    Guvakova MA; Surmacz E
    Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.